Aber 5 wäre denkbar.
|
15.12: Es ist alles denkbar! Positive, negative oder auch keine News!
Eine Zeit für News ist leider nicht zu bestimmen.
Primary end point:
Timepoint(s) of evaluation of this end point
Evaluation of the Primary endpoints will be performed at two timepoints (i.e. during two separate visits per Growth Hormone Stimulation Test): For Test 1 on Day 1, for Test 2 on D8-28 (i.e. on one day within a time period from Day8 to Day28)
Secondary end point
Timepoint(s) of evaluation of this end point Evaluation of the secondary endpoints will be:
- efficacy related at two timepoints (i.e. during two separate visits per Growth Hormone Stimulation Test), as mentioned in Section E.5.1.1: For Test 1 on Day 1, for Test 2 on D8-28 (i.e. on one day within a time period from Day8 to Day28)
- safety related at four timepoints, i.e. at all four visits of this Trial (Screening visit, Test 1, Test 2, End-of-Trial visit)
https://www.clinicaltrialsregister.eu/ctr-search/...2015-002337-22/DE
Sehe das so!
Der Secondary end point wird wohl erst nach dem Primary end point ausgewertet.
Wenn sie positive Ergebnisse ausgeben werden sie den Secondary end point mit berichten.
Bei negativen Ergebnissenbrauchen sie keinen Secondary end point für eine News.
Durch die time period from Day8 to Day28, ist natürlich keine Studienende zu errechnen.
Wednesday, October 26, 2016, wurde über den letzten Patient für die Studie berichtet.
http://ir.aezsinc.com/press-release/aezs/...onfirmatory-phase-3-trial
Wenn ich die max. Zeit mit den 28 Tage übernehme, + 2 Wochen Ausarbeitung der Ergebnisse des Primary end point, sind wir bei dem 15.12.
Aber was ist wenn sie nur 8 und nicht 28 Tage für den Test 2 gewählt haben?
Egal wie, spätestens ab dem 15.12 sehe ich die Chance auf positive Ergebnisse steigen!
Aeterna Zentaris' (AEZS) CEO David Dodd on Q3 2016 Results - Earnings Call Transcript
If we are correct on this then we would be looking at the early part of next year that we would be receiving and the process of receiving a top-line result is that the CRO whatever [indiscernible] present them, everything is reviewed, it's a very formal process as you might imagine and its signed off. And then at that point we will issue a press release and possibly hold a conference call.
Right now we're anticipating that to occur promptly - excuse me on Zoptrex that would be in early to mid February, I apologize I was thinking Macrilen. So that would be in early to mid February as everything we see going on right now.
With Macrilen, we have now ended the recruitment, we may this week complete all enrollments of the patients and all and then we will go through the process, same type of process. On a smaller scale there are about 29 sites, we previously thought there were 30 in all, but there were actually 29 full productive useful sites. So we have 29 sites, quicker process to go through, our anticipation is in the very early part of January we will be able to announce and report the top-line results for Macrilen.
http://seekingalpha.com/article/...ts-earnings-call-transcript?page=7
|
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 25 | 17.118 | Aeterna nach dem Split | Heron | Mercy | 02.05.25 19:18 | |
| 9 | 13.769 | AEZS vs. KERX | Gropius | paioneer | 03.09.22 18:22 | |
| 19 | Wie geht's jetzt weiter mit Aeterna Zentaris? | Ebi52 | Bullish_Hope | 03.08.22 00:11 | ||
| 21 | 7.680 | Aeterna Zentaris Inc. | Heron | Heron | 30.09.21 23:37 | |
| 2 | 62 | AEterna Zentaris (AEZS)- Reboundkandidat?? | Vollzeittrader | marroni | 25.04.21 13:13 |